More sessions
Resources from the American Diabetes Association provide additional context on how stable insulin function supports overall metabolic health
Understanding GLP-1 timing helps you get the best results from your treatment
Starting body weight, diet adherence, exercise levels, hydration, metabolic baseline, and sleep quality all significantly affect weekly outcomes
Semaglutide wins if you need an FDA-approved, insurance-covered, broadly accessible first-line therapy with years of proven cardiovascular outcomes data behind it
Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: a randomized, placebo-controlled, crossover study